Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Choroideremia.

Current opinion in ophthalmology - 1 Sept 2017

Dimopoulos Ioannis S, Radziwon Alina, St Laurent Chris D, MacDonald Ian M

Abstract excerpt

PURPOSE OF REVIEW: Although much has been written to define the phenotype and genotype of choroideremia (CHM), research continues to provide new insights that serve to better understand its pathogenesis and the directions for potential experimental therapies. RECENT FINDINGS: We would like to highlight new findings, expanding the type of disease-causing mutations to include mutations in the CHM promoter that will...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adaptor Proteins, Signal Transducing
Share to Choroideremia
Share to CHM gene

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genetic Therapy

Share to Mutation

Share to Phenotype

Share to Retinal Pigment Epithelium

Source

Identifiers

PMID: 28520608
DOI: 10.1097/ICU.0000000000000392

Genes

CHM

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Choroideremia.PMID 28520608Read ↗

CHOROIDEREMIASemantic proximity Read ↗

Choroideremia Gene TherapySemantic proximity Read ↗

Molecular Therapies for ChoroideremiaSemantic proximity Read ↗

Choroideremia: molecular mechanisms and development of AAV gene therapy.Semantic proximity Read ↗

Gene therapy for choroideremia: progress, potential and pitfallsSemantic proximity Read ↗

Efficacy and Safety of Retinal Gene Therapy Using Adeno-Associated Virus Vector for Patients With ChoroideremiaSemantic proximity Read ↗

Choroideremia: from genetic and clinical phenotyping to gene therapy and future treatmentsSemantic proximity Read ↗

Choroideremia: a review of general findings and pathogenesis.Semantic proximity Read ↗

Multimodal assessment of choroideremia patients defines pre-treatment characteristics.Semantic proximity Read ↗

Perspectives on Gene Therapy: Choroideremia Represents a Challenging Model for the Treatment of Other Inherited Retinal DegenerationsSemantic proximity Read ↗

Use of induced pluripotent stem cell models to probe the pathogenesis of Choroideremia and to develop a potential treatmentSemantic proximity Read ↗

Clinical findings in a carrier of a new mutation in the choroideremia gene.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.